Compounds and forms of treatment for female sexual disorders
OwnerWendy Anne Epsteininventor
Life of this patent
Estimating the term…
Abstract
The invention provides safe and efficacious treatments for Female Sexual Disorders, genitopelvic pain/penetration disorders, vulvovaginal atrophy, vestibulodynia, dyspareunia, sexual interest/arousal disorder, low female libido, and female orgasmic disorder.
Claims29
A method for treating a female sexual disorder (FSD), comprising applying a pharmaceutical composition to an individual's vulvovaginal area, wherein said pharmaceutical composition comprises a catechin having an epigallocatechin gallate component, wherein said FSD is selected from the group consisting of genitopelvic pain disorder, vulvovaginal atrophy (VVA), vestibulodynia, dyspareunia, sexual interest arousal disorder (SIAD), and female orgasmic disorder (FOD).
A method for treating a female sexual disorder (FSD) comprising applying a pharmaceutical composition comprising a catechin between about 1% and 10% weight per weight of total composition to a vulva, a vaginal introitus or a vagina of a female patient, wherein said FSD is selected from the group consisting of genitopelvic pain disorder, vulvovaginal atrophy (VVA), vestibulodynia, dyspareunia, sexual arousal disorder (SIAD), and female orgasmic disorder (FOD).
A method for treating a female sexual disorder (FSD), comprising topically applying a viscous pharmaceutical composition comprising a catechin between about 2% and 12% weight per weight of total composition to a vulva, a vaginal introitus or a vagina of a female patient wherein a vaginal maturation index of the patient remains substantially unaltered during treatment of the FSD.
A method for treating a female sexual disorder (FSD), comprising topically applying a viscous pharmaceutical composition comprising a catechin component between about 2% and 12% weight per weight of total composition and a non-catechin estrogen modulator to a vulva, a vaginal introitus or a vagina of a female patient, wherein said FSD is selected from the group consisting of genitopelvic pain disorder, vulvovaginal atrophy (VVA), vestibulodynia, dyspareunia, sexual interest arousal disorder (SIAD), and female orgasmic disorder (FOD).
Dependencies are inferred from the claim text.